,

Prostamax (Lys-Glu-Asp-Pro) | 20mg/2ml

$79.00

What is Prostamax (Lys-Glu-Asp-Pro)?

Prostamax is a synthetic tetrapeptide formulated to support prostate health and optimize cellular activity within the prostate gland. Composed of lysine, glutamic acid, aspartic acid, and proline, the peptide is designed to assist in regulating tissue growth, managing inflammation, and maintaining hormonal equilibrium.

Its targeted action on prostate cells has made it a focus in men’s health research, particularly in relation to age-associated conditions such as benign prostatic hyperplasia (BPH), chronic prostatitis, and hormone-sensitive tissue imbalances.

How does Prostamax (Lys-Glu-Asp-Pro) work?

Prostamax functions by interacting with biological processes responsible for maintaining the structural and functional integrity of the prostate:

  • Cellular Modulation in Prostate Tissue: Prostamax regulates the behavior of epithelial and stromal cells within the prostate, which may help control tissue overgrowth, promote cellular balance, and reduce abnormal proliferation associated with BPH.
  • Anti-Inflammatory Effects: Prostamax has been observed to downregulate inflammatory signaling pathways, potentially easing chronic inflammation and the symptoms that accompany it, such as pelvic discomfort and urinary obstruction.
  • Hormonal Responsiveness Control: It may help fine-tune androgen receptor activity and influence the metabolism of dihydrotestosterone (DHT), a hormone strongly linked to prostate enlargement and hormonal imbalance in men.
  • Bladder Pressure Reduction: By contributing to the reduction of prostate volume and improving tissue elasticity, Prostamax may ease pressure on the urethra and bladder neck, enhancing urinary flow and reducing urgency or frequency.

Research on Prostamax (Lys-Glu-Asp-Pro)

Research efforts surrounding Prostamax have focused on its role in the functional restoration of the prostate and modulation of prostate-related signaling:

Tissue remodeling and fibrosis prevention

Preclinical studies suggest that Prostamax may regulate extracellular matrix composition and fibroblast activity, helping to prevent fibrotic scarring and maintain soft tissue dynamics within the gland.

Antioxidant activity in prostate cells

Prostamax may activate protective cellular pathways that combat oxidative damage, which is often linked to inflammation, DNA damage, and long-term prostate tissue degeneration.

Cytokine balance and immune modulation

It has been shown to influence immune-related molecules, potentially contributing to reduced levels of TNF-α and IL-6—cytokines associated with chronic inflammation and prostate tissue stress.

DHT regulation potential

By supporting enzymatic processes that affect DHT biosynthesis, Prostamax could play a role in reducing hormone-induced prostatic hyperplasia without completely suppressing natural androgen production.

Prostamax (Lys-Glu-Asp-Pro) – Structural and Molecular Properties

Prostamax (Lys-Glu-Asp-Pro) is a synthetic tetrapeptide composed of four amino acids: Lysine (Lys), Glutamic acid (Glu), Aspartic acid (Asp), and Proline (Pro). Its structure is optimized to interact with specific cellular receptors and biological pathways, enhancing its therapeutic potential.

Compact and Stable Peptide Chain

The tetrapeptide structure of Prostamax ensures a compact and stable peptide chain that provides effective biological activity while resisting enzymatic degradation. The design of Prostamax maximizes the interaction of the peptide with cellular components, allowing it to remain active in the body and exert its therapeutic effects over a prolonged period. This stability is important for its use in long-term treatments for conditions such as inflammation, musculoskeletal recovery, and prostate health.

Enhanced Bioavailability and Stability

Due to its small size and efficient composition, Prostamax has high bioavailability, which allows it to penetrate target tissues efficiently. The short peptide chain enhances the peptide’s stability, ensuring that it remains functional within the body for extended periods, which is particularly beneficial for applications related to chronic inflammation, musculoskeletal injuries, and prostate health.

Low Immunogenicity

The simple structure of Prostamax ensures that it has low immunogenicity, meaning it is less likely to trigger unwanted immune responses when administered. This reduces the risk of allergic reactions and makes Prostamax suitable for long-term clinical use without significant immune interference. This low immunogenicity enhances Prostamax’s safety profile, making it an attractive option for prolonged treatments in immune system regulation and tissue repair.

History and Development of Prostamax (Lys-Glu-Asp-Pro)

Prostamax was developed in response to the growing need for peptide-based interventions in male reproductive and urological health. Drawing on insights from peptide bioregulation, its formulation was intended to offer a supportive, non-hormonal approach to prostate care.

The development process focused on optimizing cellular signaling and minimizing chronic inflammation—both key contributors to age-related prostate dysfunction. Today, Prostamax is under continued evaluation in preclinical and clinical settings for its role in preserving prostate function, particularly in aging men.

Benefits and Potential Applications of Prostamax (Lys-Glu-Asp-Pro)

Prostamax (Lys-Glu-Asp-Pro) is a synthetic tetrapeptide designed to support prostate health, regulate hormonal balance, and manage prostate-related issues. Its unique combination of amino acids—lysine (Lys), glutamic acid (Glu), aspartic acid (Asp), and proline (Pro)—makes it particularly effective in modulating prostate cell activity, reducing inflammation, and supporting normal prostate function. 

  • Prostate Tissue Integrity and Maintenance: Prostamax may contribute to the upkeep of healthy prostate structure by promoting cellular renewal and preventing irregular growth. This can be particularly beneficial in early-stage BPH and post-infection tissue healing.
  • Regulation of Prostate Secretions: The peptide may help balance the production and composition of prostatic fluids, which are essential for sperm viability and reproductive efficiency.
  • Pain and Discomfort Reduction: In men suffering from chronic pelvic pain or prostatitis, Prostamax’s anti-inflammatory properties may provide relief and improve quality of life by calming irritated tissues and reducing urinary discomfort.
  • Hormonal Equilibrium for Aging Men: By modulating androgen sensitivity and DHT-related activity, Prostamax supports hormonal stability, which is crucial for prostate maintenance without disturbing overall testosterone levels.
  • Preservation of Urinary Function: Its influence on tissue size and flexibility may help maintain an unobstructed urinary path, reducing symptoms such as urgency, incomplete voiding, and nighttime urination.
  • Protection Against Long-Term Complications: Prostamax may offer preventative benefits by reducing fibrotic tissue buildup and helping maintain normal prostate cell turnover, potentially lowering the risk of progression to more severe conditions.

Possible Side Effects of Prostamax (Lys-Glu-Asp-Pro)

Prostamax (Lys-Glu-Asp-Pro) has shown promising potential for improving prostate health, reducing inflammation, and supporting urinary and sexual function. However, like all bioactive peptides, there may be potential side effects, which are generally mild and transient. These effects may vary based on the individual’s health condition, dosage, and response to the peptide.

  • Mild Hormonal Fluctuations: Since Prostamax influences hormonal balance in the prostate, some users may experience temporary hormonal fluctuations. This could manifest as mild mood swings, changes in libido, or variations in sexual function as the body adjusts to the peptide’s impact on testosterone and dihydrotestosterone (DHT) levels. These changes are typically temporary and resolve as the body adapts.
  • Gastrointestinal Discomfort: In some cases, individuals may experience mild gastrointestinal symptoms, such as nausea, bloating, or stomach discomfort. These symptoms are usually short-lived and subside once the body adjusts to the peptide. To mitigate these effects, it is recommended to take Prostamax with food or adjust the dosage under the supervision of a healthcare provider.
  • Injection Site Reactions: If Prostamax is administered via subcutaneous injection, some individuals may experience mild reactions at the injection site. These can include redness, swelling, or itching at the point of administration. Such reactions are typically localized, temporary, and do not require medical attention unless they persist or worsen.
  • Fatigue or Lethargy: In some cases, individuals might experience mild fatigue or lethargy as a result of metabolic changes induced by Prostamax. This is typically a transient effect and resolves as the body acclimates to the peptide’s influence on prostate cell activity and hormonal regulation.
  • Urinary Frequency or Urgency: Some users may notice increased urinary frequency or urgency, particularly during the early stages of use. This could be due to Prostamax’s effect on prostate size and urinary flow. These symptoms are usually temporary and improve as the body adjusts to the effects of the peptide.

The side effects of Prostamax are generally mild, short-term, and dose-dependent. Most users tolerate the peptide well, but it is important to monitor any uncommon reactions or persistent symptoms.

Prostamax | Pre-Mixed Pen – Unit and Microgram (mcg), Milligram (mg) Analysis

A 20 mg Prostamax pen contains 200 units, with each unit equivalent to 100 micrograms. Example dosing scheme:

  • 1 unit = 100mcg
  • 10 units = 1mg
  • 20 units = 2mg
  • 30 units = 3mg

These parameters allow for precise dosing and flexibility in research applications.

Guaranteed Safe Checkout
Shopping Cart
error: Content is protected !!
Prostamax (Lys-Glu-Asp-Pro) | 20mg/2mlProstamax (Lys-Glu-Asp-Pro) | 20mg/2ml
$79.00
Scroll to Top